Sign in Create account

Indrayani Biotech Ltd.

Fast Moving Consumer Goods · Agricultural Food & other Products

BSE: 526445
₹10.13
▼ -0.23 (-2.22%)
Sept. 30, 2026 · BSE · bse_bhavcopy
Quality
26/100
Weak
Valuation
67/100
Fairly Valued
Momentum
46/100
Neutral

QVM read Mixed signals Quality Weak, Valuation Fairly Valued, Momentum Neutral

Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.

Key Metrics

Market Capitalization
₹46 Cr
PE (TTM)
67.5
Industry median 20.0 (105 companies)
Price to Book
0.5
PEG (TTM)
0.6
Institutions holding %
Data unavailable.
Piotroski Score
Data unavailable.
Relative return vs Nifty50, qtr %
Data unavailable.
Relative return vs Sector, qtr %
-63.4
Free Cash Flow
₹24 Cr
as of March 31, 2026
Industry median ₹-1 Cr (170 companies)
EPS Growth (YoY)
-50.00%
as of Dec. 31, 2025
Industry median 0.00% (144 companies)
Net Profit Growth (TTM)
-632.77%
as of March 31, 2026
Industry median 11.37% (141 companies)
Operating Revenue Growth (TTM)
-42.02%
as of March 31, 2026
Industry median 2.68% (143 companies)
Profit Growth (YoY)
-1879.70%
as of March 31, 2026
Industry median 8.27% (143 companies)
Revenue Growth (YoY)
-56.05%
as of March 31, 2026
Industry median 5.85% (130 companies)
Current Ratio
1.71
as of March 31, 2026
Industry median 1.58 (167 companies)
Debt to Equity
1.26
as of March 31, 2026
Industry median 0.35 (152 companies)
Interest Coverage
0.34
as of March 31, 2026
Industry median 2.71 (143 companies)
Net Margin
-88.11%
as of March 31, 2026
Industry median 4.64% (134 companies)
Operating Margin (EBIT)
-72.95%
as of March 31, 2026
Industry median 5.80% (138 companies)
Operating Margin (TTM)
6.08%
as of March 31, 2026
Industry median 4.65% (145 companies)
Return on Assets
-2.33%
as of March 31, 2026
Industry median 2.70% (146 companies)
Return on Capital Employed
1.60%
as of March 31, 2026
Industry median 8.38% (145 companies)
Return on Equity
-5.08%
as of March 31, 2026
Industry median 6.62% (146 companies)

Investment checklist

Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.

Financials

2 of 6 met
  • No Revenue is higher than a year earlier in each of the last 4 quarters
  • No Quality score is Strong (70 or more)
  • No Debt to equity is below 0.5 (1.26)
  • No Return on equity is 15% or more (-5.1%)
  • Yes Net cash flow for the latest year is positive
  • Yes Cash from operations is higher than the year before

Ownership

0 of 3 met
  • No FII/FPI or DII holding rose in the latest quarter
  • No Promoter holding rose or was unchanged in the latest quarter
  • No Promoter pledge is 5% of their holding or less and not rising (24.8% pledged)

Peer comparison

0 of 3 met
  • No 1-year return beats the industry median
  • No Revenue growth beats the industry median
  • No Profit growth beats the industry median

Value and momentum

1 of 6 met
  • Yes Price sits in the Buy zone of its own historical PE range (Undervalued (below its own historical PE range))
  • No Valuation score is Undervalued (70 or more)
  • No Momentum score is Bullish (70 or more)
  • No Price is above the 5, 10 and 20 day averages
  • No Price is above the 50, 100 and 200 day averages
  • No Latest candle has a bullish shape (hammer, dragonfly doji, white marubozu)

Price

Download CSV

PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.

RSI (14) (same adjusted close series as the price chart above)

MACD (12, 26, 9) (same adjusted close series as the price chart above)

Relative Returns (vs SENSEX)

Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.

Price range

Day return
-2.2%
Low 10.0500 · High 10.7900
1W return
7.8%
Low 9.0700 · High 10.9900
1M return
29.7%
Low 7.4000 · High 11.2900
52W return
-71.5%
Low 6.9000 · High 11.2900
Lifetime High ₹112.2500 (Sept. 21, 2022)
Lifetime Low ₹1.4900 (March 20, 2009)

Full price history and technicals →

Technicals

Full technicals, indicators & Volume/Delivery →

EMA & SMA

Bullish1
Bearish5
5D
10.2
10D
10.0
20D
10.5
50D
18.7
100D
31.1
200D
50.6

Delivery and volume

Day avg. delivery
100.0%
Week avg. delivery
100.0%
Month avg. delivery
79.5%

Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.

Resistance and support

10.32
Pivot
First resistance10.60
Second resistance11.06
Third resistance11.34
First support9.86
Second support9.58
Third support9.12
Day RSI39.1
Day MFI76.7
Day MACD-1.73
Day MACD signal-2.71

Beta

1M-1.71
3M-1.24
1Y-1.24
3Y0.44

Price change analysis

↑ 29.7%
Over 1 Month
LowHigh
7.4011.29
↓ -71.5%
Over 3 Months
LowHigh
6.9011.29
↓ -71.5%
Over 6 Months
LowHigh
6.9011.29
↓ -71.5%
Over 1 Year
LowHigh
6.9011.29
Legend Positive indicator Neutral indicator Negative indicator

Buy/Sell Zone

View Buy/Sell Zone →
Current PE 67.5 (own history: 98.7–507.6)
Undervalued (below its own historical PE range)

Financials

View full financials, peers & valuation multiples →
Revenue (March 31, 2026)
₹4 Cr
Net profit (March 31, 2026)
₹-4 Cr
Basic EPS (March 31, 2026)
₹0.0100

Ranks #106 of 152 in Agricultural Food & other Products by market cap -- full peer table on the Financials page.

Shareholding pattern / Ownership

Shareholding summary

Jun 2026
  • Promoter32.92%

Largest holders

Data unavailable.

Historical promoter holding

Promoters holdings decreased from 33.26% to 32.92% in Jun 2026 qtr

Historical mutual fund holding

All shareholding details →

Deals (Bulk & Block)

All 27 deals, with filters and CSV →
DateClientDealActionQuantityPriceExchange
5 Jun 2026 VITRAG SEVENTEEN FAMILY TRUST Bulk Buy 400,000 11.4500 BSE
5 Jun 2026 AMBA INVESTORS AOP Bulk Sell 400,000 11.4500 BSE
6 Nov 2025 GURURAJ PRIYADARSHINI Bulk Buy 300,944 15.4400 BSE
28 Mar 2025 NEXT ORBIT VENTURES FUND Bulk Sell 250,000 14.1400 BSE
28 Mar 2025 PARIMALA KRISHNAMURTHY Bulk Buy 298,500 14.1400 BSE
27 Mar 2025 LRSD SECURITIES PRIVATE LIMITED Bulk Buy 250,000 14.8200 BSE
27 Jun 2024 TOPGAIN FINANCE PRIVATE LIMITED Bulk Sell 137,325 58.6000 BSE
27 Jun 2024 SAHASTRAA ADVISORS PRIVATE LIMITED Bulk Sell 267,714 58.6000 BSE
27 Jun 2024 TOPGAIN FINANCE PRIVATE LIMITED Bulk Buy 351,626 59.4600 BSE
27 Jun 2024 RAJASTHAN GLOBAL SECURITIES PRIVATE LIMITED Bulk Buy 952,945 58.6000 BSE

All bulk and block deals →

Corporate Announcements

All 6 announcements, with search →

Exchange disclosures (NSE and BSE), most recent first.

DateCategoryAnnouncement
30 Sep 2026 Board Meeting Indrayani Biotech Ltd - 526445 - Board Meeting Intimation for Board Meeting Intimation For Board Meeting Intimation For Intimation For Board Meeting To Be Held On 7Th October, 2026
29 Sep 2026 Insider Trading / SAST Indrayani Biotech Ltd - 526445 - Closure of Trading Window
15 Sep 2026 Company Update Indrayani Biotech Ltd - 526445 - Announcement under Regulation 30 (LODR)-Newspaper Publication
9 Sep 2026 Company Update Indrayani Biotech Ltd - 526445 - Letter Of Offer For Rights Issue
9 Sep 2026 Company Update Indrayani Biotech Ltd - 526445 - Appointment of Company Secretary and Compliance Officer
9 Sep 2026 Corp. Action Indrayani Biotech Ltd - 526445 - Corporate Action-Outcome of Right issue

All announcements →

SWOT

Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.

Strengths

  • Healthy liquidity (Current Ratio 1.71)

Weaknesses

  • Low Return on Equity (-5.1%)
  • Thin net profit margin (-88.1%)
  • High financial leverage (Debt/Equity 1.26)
  • Declining revenue YoY (-56.0%)
  • Declining profit YoY (-1879.7%)

Opportunities

  • PEG below 1 (0.59) -- earnings growth outpacing its own valuation
  • Trading below book value (PB 0.45)

Threats

  • PE above 35 (67.5) -- priced for continued strong execution
  • Down 71.5% over the past year
  • Weak interest coverage (0.3x) -- limited cushion against rising rates

Board of directors and corporate information →

F&O

View F&O, Options & Backtest →

Data unavailable (no single-stock futures or options activity on record for this company).

Frequently asked questions about Indrayani Biotech Ltd.

Where is the share price?

The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.

Where are the financial results?

The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.

Who owns the company?

The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.

Does Tradinity give buy or sell advice?

No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.